Ketamine could soon be approved to treat depression


Psychiatrists looking for a new treatment to give patients with major depression and suicidal tendencies may soon be able to administer ketamine inside of their offices.
If ketamine is approved by the Federal Drug Administration as a breakthrough therapy, it will be the first new treatment for a major depressive disorder in about 50 years, CNN reports. On Tuesday, Janssen Pharmaceutical announced it is working on two clinical trials with ketamine — one for treatment-resistant depression and one for depression with suicidal thoughts, and will present the data to the FDA in 2018. Ketamine is also known as the street drug Special K, which gives users the feeling of being out of their body. It was used in the 1960s as an analgesic and sedative and is still on the World Health Organization's Essential Medicine List, but because of its hallucinogenic side effects, it's mostly used today as a veterinary anesthetic.
Depression causes damage to nerves and their transmission pathways, and research leads scientists to believe ketamine remodels those nerves, triggering neuroplastic processes that make new connections among brain cells, Dr. Dan Iosifescu of the Icahn School of Medicine at Mount Sinai in New York City told CNN. "What's unique about ketamine is, this happens in hours or days, while with other depression medications, this happens in weeks to months," he said. Doctors have some concern that using ketamine for depression could reverse a person's tolerance to opioids or lead to substance abuse, and Janssen said its formulation would only be administered by a doctor in their office.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Japan poised to get first woman prime minister
Speed Read The ruling Liberal Democratic Party elected former Economic Security Minister Sanae Takaichi
-
Israel and Hamas meet on hostages, Trump’s plan
Speed Read Hamas accepted the general terms of Trump’s 20-point plan, including the release of all remaining hostages
-
US tipped to help Kyiv strike Russian energy sites
Speed Read Trump has approved providing Ukraine with intelligence for missile strikes on Russian energy infrastructure
-
Netanyahu agrees to Trump’s new Gaza peace plan
Speed Read At President Trump's meeting with Israeli Prime Minister Benjamin Netanyahu, they agreed upon a plan to end Israel’s war in Gaza
-
Russia is ‘helping China’ prepare for an invasion of Taiwan
In the Spotlight Russia is reportedly allowing China access to military training
-
Moldova gives decisive win to pro-EU party
Speed Read The country is now on track to join the European Union within five years
-
Interpol arrests hundreds in Africa-wide sextortion crackdown
IN THE SPOTLIGHT A series of stings disrupts major cybercrime operations as law enforcement estimates millions in losses from schemes designed to prey on lonely users
-
UK, 3 Western allies recognize Palestinian state
Speed Read Britain, Canada, Australia and Portugal formally recognized the state of Palestine